INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 412m ago
HOUSE PTR11m ago
SEC 13F11m ago
ROBINHOOD CHAIN11m ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Piscitelli Dominic sold ORIC

Chief Financial Officer · Oric Pharmaceuticals, Inc. · Common Stock

Side
SELL
Value
$1.05M
Shares
77.0K
Price
$13.69
Executed
Aug 26, 2026
Disclosed
Aug 28, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 26 executedAug 28, 2026 disclosed

ORIC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
26/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+22 / 25

    $1.1M reported value · 52.4% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ORIC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    6
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M$61K
    14.0K sh
    		Oct 20, 2026Oct 21, 2026
    traded Oct 20, 2026
    		+1dSEC FORM 4

    Evidence

    8
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$189K
    14.0K sh
    		Oct 20, 2026Oct 21, 2026
    traded Oct 20, 2026
    		+1dSEC FORM 4

    Evidence

    3
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M—
    14.0K sh
    		Oct 20, 2026Oct 21, 2026
    traded Oct 20, 2026
    		+1dSEC FORM 4

    Evidence

    8
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$181K
    13.4K sh
    		Sep 28, 2026Sep 29, 2026
    traded Sep 28, 2026
    		+1dSEC FORM 4

    Evidence

    2
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M$58K
    13.4K sh
    		Sep 28, 2026Sep 29, 2026
    traded Sep 28, 2026
    		+1dSEC FORM 4

    Evidence

    3
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M—
    13.4K sh
    		Sep 28, 2026Sep 29, 2026
    traded Sep 28, 2026
    		+1dSEC FORM 4

    Evidence

    0
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M—
    600 sh
    		Sep 24, 2026Sep 25, 2026
    traded Sep 24, 2026
    		+1dSEC FORM 4

    Evidence

    1
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1,350
    100 sh
    		Sep 24, 2026Sep 25, 2026
    traded Sep 24, 2026
    		+1dSEC FORM 4

    Evidence

    1
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$6,753
    500 sh
    		Sep 24, 2026Sep 25, 2026
    traded Sep 24, 2026
    		+1dSEC FORM 4

    Evidence

    0
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M$2,616
    600 sh
    		Sep 24, 2026Sep 25, 2026
    traded Sep 24, 2026
    		+1dSEC FORM 4

    Evidence

    11
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M—
    52.0K sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    7
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M—
    25.0K sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    14
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M$227K
    52.0K sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    10
    PD
    Piscitelli DominicChief Financial Officer
    ORICOric Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M$150K
    25.0K sh
    		Aug 26, 2026Aug 28, 2026
    traded Aug 26, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001695028-26-000006
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 26, 2026
    Published
    Aug 28, 2026
    Ingested by INSIDER
    Nov 5, 02:20 UTC
    Last re-read
    Nov 5, 02:20 UTC

    Extracted facts

    Filer
    Piscitelli Dominic
    Role
    Chief Financial Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Oric Pharmaceuticals, Inc.
    Ticker
    ORIC
    Shares
    77.0K
    Price per share
    $13.69
    Value
    $1,053,814
    Execution date (reported)
    Aug 26, 2026
    Owned after transaction
    69.8K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 77.0K
    • Price: $13.6859

    = $1,053,814

    What this establishes

    Piscitelli Dominic filed this Form 4 reporting a open-market sale of ORIC on Aug 26, 2026. It became public on Aug 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Financial Officer
    Piscitelli Dominiccik:0001695028
    Issuer
    Oric Pharmaceuticals, Inc.cik:0001796280

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.